Tirzepatide studies: 457 papers with results
Page 8 of 10
- GLP-1 Receptor Agonist-Associated Slimmer's Palsy: Implications for the Peripheral Nerve Surgeon.
Dhupati P · Annals of plastic surgery · 2026
Case report or series · 4 results
- Tirzepatide-Induced Liver Injury: A Rare Complication.
Spaeth LD · AACE endocrinology and diabetes · 2026
Case report or series · 8 results
- Tirzepatide non-response with subsequent semaglutide response in class 2 obesity.
La Vignera S · JCEM case reports · 2026
Case report or series · 5 results
- Mixed Medullary and Papillary Thyroid Carcinoma in a Patient on Tirzepatide.
Beshay LH · Cureus · 2026
Case report or series · 1 result
- Ischemic Colitis Associated With Tirzepatide Therapy in a Young Female Patient: A Case Report.
Sekhon S · Cureus · 2026
Case report or series · 3 results
- Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women.
Mohammed A · AACE endocrinology and diabetes · 2026
Case report or series · 6 results
- Acute Duodenal Ulcer Perforation Following Tirzepatide Treatment: A Case Report.
Hayashi M · Cureus · 2025
Case report or series · 3 results
- Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.
Ciudin A · Diabetes, obesity & metabolism · 2025
Other design · 13 results
- Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison.
Hankosky ER · Diabetes, obesity & metabolism · 2025
Other design · 6 results
- Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison.
Osumili B · Diabetes research and clinical practice · 2024
Other design · 9 results
- Comparative Analysis of Pioglitazone and Tirzepatide on Body Weight, Glucose Levels, Neuroinflammation, and Oxidative Stress in Diabetic Rats.
Alhowail A · Drug design, development and therapy · 2025
Animal study (in vivo) · rat · 6 results
- Possible protective effects of tirzepatide on polycystic ovary syndrome in female rat model induced by testosterone propionate in comparison to metformin.
Olewi NZ · Naunyn-Schmiedeberg's archives of pharmacology · 2026
Animal study (in vivo) · rat · 18 results
- Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.
Ma J · Endocrine · 2025
Animal study (in vivo) · mouse · 19 results
- Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide.
Hegedűs ZI · Cardiovascular diabetology · 2025
Animal study (in vivo) · mouse · 18 results
- ARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition.
Zheng Z · Molecular metabolism · 2026
Animal study (in vivo) · mouse · 1 result
- Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats.
Windram M · Psychopharmacology · 2026
Animal study (in vivo) · rat · 5 results
- Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison.
Hitaka K · International journal of obesity (2005) · 2026
Animal study (in vivo) · mouse · 37 results
- Comparative analysis of LJ-4378 and tirzepatide in mouse models of obesity and weight regain.
Kim H · Archives of pharmacal research · 2025
Animal study (in vivo) · mouse · 8 results
- Calorie restriction activates a gastric Notch-FOXO1 pathway to expand ghrelin cells.
McKimpson WM · The Journal of cell biology · 2024
Animal study (in vivo) · mouse · 2 results
- Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.
Ding M · iScience · 2026
Animal study (in vivo) · mouse · 9 results
- Mitochondrial Adaptations in Skeletal Muscle Following Incretin-Based Therapies: In Vitro.
Old V · Journal of cachexia, sarcopenia and muscle · 2026
In vitro (cells) · mouse · 22 results
- Sleeve gastrectomy versus tirzepatide to improve survival among patients with stage 5 CKD: A Markov decision analysis.
Di Napoli M · American journal of surgery · 2026
In silico · 4 results
- Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States.
Liu L · Journal of managed care & specialty pharmacy · 2025
In silico · 12 results
- 5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.
Niu S · Diabetes, obesity & metabolism · 2024
In silico · 9 results
- Less frequent dosing of GLP-1 receptor agonists as a viable weight maintenance strategy.
Wu CC · Obesity (Silver Spring, Md.) · 2025
In silico · 4 results
- Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide.
Hu S · Diabetes, obesity & metabolism · 2024
In silico · 6 results
- The cost-utility and budget impact analyses of Tirzepatide versus once-weekly Semaglutide as add-on therapy to metformin in patients with type 2 diabetes mellitus in China.
Wang S · Diabetes, obesity & metabolism · 2025
In silico · 7 results
- Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Johansson E · Journal of medical economics · 2026
In silico · 6 results
- Impact of GLP-1 receptor agonists on stroke, subarachnoid hemorrhage, and intracerebral hemorrhage: a propensity-matched multi-institutional cohort study.
Costa M · Journal of neurosurgery · 2026
Not a test of Tirzepatide alone · 80 results
- Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Galli M · Journal of the American College of Cardiology · 2025
Not a test of Tirzepatide alone · 45 results
- Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis.
Ko A · Annals of internal medicine · 2026
Not a test of Tirzepatide alone · 26 results
- Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system.
McCall KL · Expert opinion on drug safety · 2026
Not a test of Tirzepatide alone · 36 results
- Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy.
Shah J · American journal of ophthalmology · 2026
Not a test of Tirzepatide alone · 48 results
- Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial.
Stewart KD · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
Not a test of Tirzepatide alone · 24 results
- Association of long-term weight management pharmacotherapy with multiple health outcomes: an umbrella review and evidence map.
Lu TT · International journal of obesity (2005) · 2025
Not a test of Tirzepatide alone · 35 results
- Efficacy and safety of GLP-1 receptor agonists in the treatment of obese patients with chronic heart failure: a meta-analysis.
Jia A · Frontiers in cardiovascular medicine · 2025
Not a test of Tirzepatide alone · 33 results
- Comparison of IBD-related outcomes in patients with obesity treated with GLP-1 receptor agonists versus bariatric surgery.
Nanah MH · Crohn's & colitis 360 · 2026
Not a test of Tirzepatide alone · 44 results
- Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.
Wang Y · The Journal of clinical endocrinology and metabolism · 2025
Not a test of Tirzepatide alone · 32 results
- Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024.
Alibilli AS · JMIR infodemiology · 2025
Not a test of Tirzepatide alone · 15 results
- Effectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: A real-world observational study.
Talay L · Diabetes, obesity & metabolism · 2026
Not a test of Tirzepatide alone · 10 results
- Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis.
Santos Solis R · Cureus · 2026
Not a test of Tirzepatide alone · 30 results
- Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis.
Nieto LM · The American journal of gastroenterology · 2026
Not a test of Tirzepatide alone · 36 results
- A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies.
Daniel S · Journal of drugs in dermatology : JDD · 2025
Not a test of Tirzepatide alone · 27 results
- Incretin-Based Dual and Triple Agonists in Overweight or Obese Individuals: A Systematic Review and Meta-Analysis.
Chan ZH · Cardiology in review · 2026
Not a test of Tirzepatide alone · 27 results
- Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.
St-Pierre J · Digestive diseases and sciences · 2024
Not a test of Tirzepatide alone · 16 results
- Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction- Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide.
Caussy C · Diabetes care · 2025
Not a test of Tirzepatide alone · 8 results
- GLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study.
Gonzalez F · Journal of pediatric endocrinology & metabolism : JPEM · 2026
Not a test of Tirzepatide alone · 24 results
- Preoperative GLP-1 Receptor Agonists and Thromboinflammatory Markers in Patients Undergoing Abdominoplasty: A Prospective Monocentric Study.
Bruno A · Aesthetic plastic surgery · 2026
Not a test of Tirzepatide alone · 16 results
- Weight Loss-Dependent Changes in Body Composition and Bone Health in People With Obesity and Type 1 Diabetes Treated With Liraglutide, Semaglutide, or Tirzepatide.
Al Ozairi E · Diabetes/metabolism research and reviews · 2026
Not a test of Tirzepatide alone · 24 results
- Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.
Capehorn M · Advances in therapy · 2025
Not a test of Tirzepatide alone · 13 results